Literature DB >> 11105370

Drug-related pemphigus and angiotensin converting enzyme inhibitors.

C S Ong1, N Cook, S Lee.   

Abstract

A 105-year-old woman developed pemphigus foliaceus. She had been on fosinopril, an angiotensin-converting enzyme inhibitor (ACE inhibitor) for 4 years. Anti-intercellular cement substance antibodies were positive with titre > 160. She died during admission of an unrelated illness. A 57-year-old man developed pemphigus vulgaris after 11 months treatment with quinapril. At 14 months after developing pemphigus, this man continues on prednisone and azathioprine. We speculate that these are cases of ACE-inhibitor-related pemphigus and we review ACE-inhibitor-related pemphigus.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11105370     DOI: 10.1046/j.1440-0960.2000.00445.x

Source DB:  PubMed          Journal:  Australas J Dermatol        ISSN: 0004-8380            Impact factor:   2.875


  5 in total

Review 1.  Diagnosis and clinical features of pemphigus foliaceus.

Authors:  Kirk A James; Donna A Culton; Luis A Diaz
Journal:  Dermatol Clin       Date:  2011-07       Impact factor: 3.478

2.  Systematic drug repositioning based on clinical side-effects.

Authors:  Lun Yang; Pankaj Agarwal
Journal:  PLoS One       Date:  2011-12-21       Impact factor: 3.240

3.  Serum Angiotensin converting enzyme in pemphigus vulgaris.

Authors:  Reza M Robati; Azin Ayatollahi; Parviz Toossi; Shima Younespour
Journal:  Indian J Dermatol       Date:  2014-07       Impact factor: 1.494

4.  A retrospective study of antihypertensives in pemphigus: a still unchartered odyssey particularly between thiols, amides and phenols.

Authors:  Paweł Pietkiewicz; Justyna Gornowicz-Porowska; Monika Bowszyc-Dmochowska; Marian Dmochowski
Journal:  Arch Med Sci       Date:  2015-10-12       Impact factor: 3.318

Review 5.  Orofacial manifestations of adverse drug reactions: a review study.

Authors:  Sedigheh Bakhtiari; Marziye Sehatpour; Hamed Mortazavi; Mahin Bakhshi
Journal:  Clujul Med       Date:  2018-01-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.